PAFAH1B3 is a KLF9 Target Gene That Promotes Proliferation and Metastasis in Pancreatic Cancer

Overview

Journal Sci Rep

Specialty Science

Date 2024 Apr 22

PMID 38649699

Authors

Cairong Dong

Jinping Yao

Zhipeng Wu

Junwen Hu

Liang Sun

Zhengyi Wu

Jinlong Yan

Xiangbao Yin

Affiliations

Soon will be listed here.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. Uncontrolled cell proliferation, invasion and migration of pancreatic cancer cells are the fundamental causes of death in PDAC patients. Our previous studies showed that KLF9 inhibits the proliferation, invasion and migration of pancreatic cancer cells. However, the underlying mechanisms are not fully understood. In this study, we found that platelet-activating factor acetylhydrolase IB3 (PAFAH1B3) is highly expressed in pancreatic cancer tissues and cells. In vitro and in vivo studies showed that overexpression of PAFAH1B3 promoted the proliferation and invasion of pancreatic cancer cells, while downregulation of PAFAH1B3 inhibited these processes. We found that KLF9 expression is negatively correlated with PAFAH1B3 expression in pancreatic cancer tissues and cells. Western blotting revealed that KLF9 negatively regulates the expression of PAFAH1B3 in pancreatic cancer tissues and cells. Rescue experiments showed that overexpression of PAFAH1B3 could partially attenuate the suppression of pancreatic cancer cell proliferation, invasion and migration induced by KLF9 overexpression. Finally, chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays were carried out, and the results showed that KLF9 directly binds to the promoter of PAFAH1B3 and inhibits its transcriptional activity. In conclusion, our study indicated that KLF9 can inhibit the proliferation, invasion, migration and metastasis of pancreatic cancer cells by inhibiting PAFAH1B3.

References

Li Y, Li Y, Luo J, Fu X, Liu P, Liu S . FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K/AKT signaling pathway. Cell Death Discov. 2022; 8(1):248. PMC: 9072533. DOI: 10.1038/s41420-022-01047-9. View

Hsu H, Wu P, Chen C, Hsu L, Yeh C, Hsing M . High cytoplasmic expression of Krüppel-like factor 4 is an independent prognostic factor of better survival in hepatocellular carcinoma. Int J Mol Sci. 2014; 15(6):9894-906. PMC: 4100128. DOI: 10.3390/ijms15069894. View

Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C . Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat Oncol. 2019; 14(1):141. PMC: 6688256. DOI: 10.1186/s13014-019-1345-6. View

Desai P, Ann D, Wang J, Prabhu S . Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies. Crit Rev Ther Drug Carrier Syst. 2019; 36(1):59-91. DOI: 10.1615/CritRevTherDrugCarrierSyst.2018025459. View

Xu J, Zang Y, Cao S, Lei D, Pan X . Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma. Onco Targets Ther. 2019; 12:2799-2808. PMC: 6469483. DOI: 10.2147/OTT.S196324. View

Okuyama A, Saika K . Pancreas cancer incidence rates in the world from the Cancer Incidence in Five Continents XI. Jpn J Clin Oncol. 2018; 48(11):1028-1029. DOI: 10.1093/jjco/hyy148. View

Kang L, Lu B, Xu J, Hu H, Lai M . Downregulation of Krüppel-like factor 9 in human colorectal cancer. Pathol Int. 2008; 58(6):334-8. DOI: 10.1111/j.1440-1827.2008.02233.x. View

Haeberle L, Esposito I . Pathology of pancreatic cancer. Transl Gastroenterol Hepatol. 2019; 4:50. PMC: 6624347. DOI: 10.21037/tgh.2019.06.02. View

Huang S, Wang C, Yi Y, Sun X, Luo M, Zhou Z . Krüppel-like factor 9 inhibits glioma cell proliferation and tumorigenicity via downregulation of miR-21. Cancer Lett. 2014; 356(2 Pt B):547-55. DOI: 10.1016/j.canlet.2014.10.007. View

10.

Fan J, Yang Y, Qian J, Zhang X, Ji J, Zhang L . Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma. Front Oncol. 2021; 11:664478. PMC: 8201501. DOI: 10.3389/fonc.2021.664478. View

11.

Hsu L, Huang R, Lai H, Hsu H, Sung W, Hsieh M . KLF6 inhibited oral cancer migration and invasion via downregulation of mesenchymal markers and inhibition of MMP-9 activities. Int J Med Sci. 2017; 14(6):530-535. PMC: 5479121. DOI: 10.7150/ijms.19024. View

12.

Horsfall A, Abell A, Bruning J . Targeting PCNA with Peptide Mimetics for Therapeutic Purposes. Chembiochem. 2019; 21(4):442-450. DOI: 10.1002/cbic.201900275. View

13.

Nilsson R, Jain M, Madhusudhan N, Gustafsson Sheppard N, Strittmatter L, Kampf C . Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun. 2014; 5:3128. PMC: 4106362. DOI: 10.1038/ncomms4128. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

Seyfried T, Huysentruyt L . On the origin of cancer metastasis. Crit Rev Oncog. 2012; 18(1-2):43-73. PMC: 3597235. DOI: 10.1615/critrevoncog.v18.i1-2.40. View

16.

Baum B, Georgiou M . Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol. 2011; 192(6):907-17. PMC: 3063136. DOI: 10.1083/jcb.201009141. View

17.

Kaczynski J, Cook T, Urrutia R . Sp1- and Krüppel-like transcription factors. Genome Biol. 2003; 4(2):206. PMC: 151296. DOI: 10.1186/gb-2003-4-2-206. View

18.

Ji P, Fan X, Ma X, Wang X, Zhang J, Mao Z . Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5. Biochem Biophys Res Commun. 2018; 499(4):815-821. DOI: 10.1016/j.bbrc.2018.03.229. View

19.

Brown A, Simmen R, Raj V, Van T, MacLeod S, Simmen F . Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling. Carcinogenesis. 2015; 36(9):946-55. PMC: 4573661. DOI: 10.1093/carcin/bgv104. View

20.

Kumari R, Majumder M, Lievonen J, Silvennoinen R, Anttila P, Nupponen N . Prognostic significance of esterase gene expression in multiple myeloma. Br J Cancer. 2021; 124(8):1428-1436. PMC: 8039029. DOI: 10.1038/s41416-020-01237-1. View